CVA Family Office’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Sell |
110
-75
| -41% | -$6.84K | ﹤0.01% | 800 |
|
|
2025
Q1 | $20.9K | Sell |
185
-18
| -9% | -$2.04K | ﹤0.01% | 675 |
|
|
2024
Q4 | $21.4K | Buy |
203
+118
| +139% | +$12.5K | ﹤0.01% | 665 |
|
|
2024
Q3 | $9.18K | Sell |
85
-85
| -50% | -$9.18K | ﹤0.01% | 768 |
|
|
2024
Q2 | $18.5K | Buy |
170
+81
| +91% | +$8.79K | ﹤0.01% | 654 |
|
|
2024
Q1 | $11.7K | Buy |
89
+4
| +5% | +$528 | ﹤0.01% | 724 |
|
|
2023
Q4 | $10.3K | Buy |
+85
| New | +$10.3K | ﹤0.01% | 721 |
|
|
2023
Q3 | – | Sell |
-95
| Closed | -$13.8K | – | 986 |
|
|
2023
Q2 | $13.8K | Buy |
95
+5
| +6% | +$728 | ﹤0.01% | 674 |
|
|
2023
Q1 | $11.6K | Sell |
90
-10
| -10% | -$1.29K | ﹤0.01% | 672 |
|
|
2022
Q4 | $12.8K | Buy |
100
+15
| +18% | +$1.91K | ﹤0.01% | 630 |
|
|
2022
Q3 | $9K | Sell |
85
-160
| -65% | -$16.9K | ﹤0.01% | 650 |
|
|
2022
Q2 | $26K | Hold |
245
| – | – | 0.01% | 497 |
|
|
2022
Q1 | $31K | Sell |
245
-146
| -37% | -$18.5K | 0.01% | 492 |
|
|
2021
Q4 | $48K | Buy |
+391
| New | +$48K | 0.01% | 370 |
|
|
2021
Q3 | – | Sell |
-77
| Closed | -$12K | – | 906 |
|
|
2021
Q2 | $12K | Sell |
77
-26
| -25% | -$4.05K | ﹤0.01% | 622 |
|
|
2021
Q1 | $16K | Buy |
+103
| New | +$16K | 0.01% | 455 |
|